Citations

Clear

4802 citation(s) found for "Yu, Jennifer".

Loss of Methylthioadenosine Phosphorylase by Immunohistochemistry Is Common in Pulmonary Sarcomatoid Carcinoma and Sarcomatoid Mesothelioma
Terra, Simone , Roden, Anja C. , Yi, Eunhee S. , Aubry, Marie Christine, Boland, Jennifer M.

Mayo Clinic

American Journal of Clinical Pathology | April 26, 2021 | Volume: 157 | Issue: 1 | Pages: 33-39

10.1093/ajcp/aqab091 | PMID 34463336 Get It

Abstract Objectives Differentiating malignant pleural mesothelioma from benign reactive mesothelial processes can be quite challenging. Ancillary tests such as BRCA1-associated protein 1 (BAP1) immunohistochemistry and p16 fluorescence in situ hybridization (FISH) are helpful tools to aid in this distinction. Immunohistochemistry for methylthioadenosine phosphorylase (MTAP) has recently been proposed as an effective surrogate marker for p16 FISH and is an attractive alternative test due to shorter turnaround time. There are little data regarding the specificity of MTAP loss for mesothelioma or whether it may be useful to distinguish mesothelioma from the most common entity in the differential diagnosis, sarcomatoid carcinoma. Methods We studied well-characterized cases of sarcomatoid carcinoma (n = 34) and sarcomatoid mesothelioma (n = 62), which were stained for MTAP (clone 2G4) and BAP1 (clone C-4). Results Loss of MTAP expression was observed in 17 (50%) of 34 pulmonary sarcomatoid carcinomas; BAP1 expression was retained in all of the cases in which it was performed (n = 31). MTAP expression was lost in 38 (61%) of 62 sarcomatoid mesotheliomas; BAP1 was lost in 6 (10%) of 62. In the six cases with BAP1 loss, five also had loss of MTAP, while MTAP expression was retained in one. Conclusions Loss of MTAP expression by immunohistochemistry is common in pulmonary sarcomatoid carcinoma, as it is present in half of cases. This rate is similar to what is observed in sarcomatoid mesothelioma (61%). Therefore, this stain is not useful to distinguish between these two malignancies. MTAP loss is more common than BAP1 loss in the setting of sarcomatoid mesothelioma (61% vs 10%, respectively).
Clinical Characteristics, Outcomes, Disposition, and Acute Care of Children and Adolescents Treated for Acetaminophen Toxicity
Shekunov, Julia , Lewis, Charles P. , Voort, Jennifer L. Vande , Bostwick, John , Romanowicz, Magdalena , Vande Voort, Jennifer L., Bostwick, J Michael

Mayo Clinic

Psychiatric Services | April 23, 2021 | Volume: 72 | Issue: 7 | Pages: 758-765

10.1176/appi.ps.202000081 | PMID 33887959 Get It

The Effect of Tolvaptan on BP in Polycystic Kidney Disease: A Post Hoc Analysis of the TEMPO 3:4 Trial
Heida, Judith E. , Gansevoort, Ron T. , Torres, Vicente E. , Devuyst, Olivier , Perrone, Ronald D. , Lee, Jennifer , Li, Hui , Ouyang, John , Chapman, Arlene B., Torres, Vicente E , Torres, Vicente E , Devuyst, Olivier; https://orcid.org/0000-0003-3744-4767

Mayo Clinic

Journal of the American Society of Nephrology | April 22, 2021 | Volume: 32 | Issue: 7 | Pages: 1801-1812

10.1681/asn.2020101512 | PMID 33888577 Get It

Significance Statement Patients with autosomal dominant polycystic kidney disease are treated with tolvaptan, a V2 receptor antagonist, to slow progression toward ESKD. In theory, tolvaptan could have both BP-increasing and BP-decreasing effects. To investigate the magnitude and time course of the effect of tolvaptan use on BP, the authors conducted a post hoc analysis of data from the TEMPO 3:4 trial, which randomized 1445 patients with autosomal dominant polycystic kidney disease to tolvaptan or placebo. Their analysis shows that directly after start of tolvaptan therapy, BP does not change, but in the long term, BP gradually becomes lower in patients with tolvaptan compared with placebo. This observation might be attributed to the beneficial effect of tolvaptan on disease progression, a sustained natriuretic effect, or both. Background The V2 receptor antagonist tolvaptan is prescribed to patients with autosomal dominant polycystic kidney disease to slow disease progression. Tolvaptan may alter BP via various acute and chronic effects. Methods To investigate the magnitude and time course of the effect of tolvaptan use on BP, we conducted a post hoc study of the TEMPO 3:4 trial, which included 1445 patients with autosomal dominant polycystic kidney disease randomized 2:1 to tolvaptan or placebo for 3 years. We evaluated systolic and diastolic BP, mean arterial pressure, hypertension status, and use and dosing of antihypertensive drugs over the course of the trial. Results At baseline, BP did not differ between study arms. After 3 weeks of tolvaptan use, mean body weight had decreased from 79.7 to 78.8 kg, and mean plasma sodium increased from 140.4 to 142.6 mmol/L (both P <0.001), suggesting a decrease in circulating volume. We observed none of these changes in the placebo arm. Nonetheless, BP remained similar in the study arms. After 3 years of treatment, however, mean systolic BP was significantly lower in participants receiving tolvaptan versus placebo (126 versus 129 mm Hg, respectively; P =0.002), as was mean diastolic BP (81.2 versus 82.6 mm Hg, respectively; P =0.01). These differences leveled off at follow-up 3 weeks after discontinuation of the study medication. Use of antihypertensive drugs remained similar in both study arms during the entire study. Conclusions Long-term treatment with tolvaptan gradually lowered BP compared with placebo, which may be attributed to a beneficial effect on disease progression, a continued natriuretic effect, or both. Clinical Trial registry name and registration number: TEMPO 3:4, NCT00428948
Introducing Lifestyle Medicine Within the Mayo Clinic Alix School of Medicine in Arizona
Drost, Jennifer M. , Lucas, Pauline H., Patchett, David , Hatley, Melissa R., Scales, Robert , Patchett, David C, Johnson, Daniel C, Lucas, Pauline , Johnson, Daniel

Mayo Clinic

American Journal of Lifestyle Medicine | April 22, 2021 | Volume: 15 | Issue: 6 | Pages: 612-618

10.1177/15598276211007824 | PMID 34916881 Get It

Purpose: High-value care is becoming increasingly important as the United States shifts toward a more sustainable health care system. Lifestyle medicine (LM) may be the highest-value model of care. Surprisingly, however, it is taught in a minority of medical schools. In this article, we describe a pilot project of introducing a brief LM course taught within the Mayo Clinic Alix School of Medicine in Arizona. The main purpose of the course was to introduce the students to LM as a specialty practice and to provide students with foundational knowledge of the pillars of LM. Results: Students reported improved personal health habits and increased confidence in LM competencies.
Right‐to‐left shunt detection using transforaminal insonation of the basilar artery
Chhabra, Nikita , Kumar, Gyanendra , Fruin, Jennifer, Dumitrașcu, Oana

Mayo Clinic

Journal of Neuroimaging | April 21, 2021 | Volume: 31 | Issue: 4 | Pages: 696-700

10.1111/jon.12855 | PMID 33878227 Get It

ABSTRACTBACKGROUND AND PURPOSEInvestigation for patent foramen ovale (PFO) is warranted in patients with cryptogenic stroke (CS), as PFO closure is recommended in select CS patients for secondary stroke prevention. Transcranial Doppler (TCD) is noninvasive and has high sensitivity for PFO screening. However, 10% of the population has insufficient temporal bone windows to perform standard TCD monitoring of the middle cerebral arteries (MCAs). Prior reports showed similar diagnostic accuracy between the basilar artery and MCAs insonation. Our objective was to assess the accuracy of transforaminal insonation of the basilar artery (TIBA) in diagnosis of right‐to‐left shunt (RLS) in patients with inadequate temporal windows.METHODSWe performed a retrospective, single‐center, observational study of TIBA in patients with CS and inadequate temporal windows. We compared the PFO screening accuracy using TIBA versus echocardiogram, either transthoracic (TTE) or transesophageal echocardiogram (TEE).RESULTSSixteen females and four males were included (mean age 63.2). All patients underwent TTE, 10 (50%) underwent gold‐standard TEE. Nine patients had positive PFO with both TCD and echocardiogram. Two patients with negative echocardiogram had TCD‐positive shunt. Three patients had PFO present on echocardiogram, whereas TCD was negative. Six patients had absent shunt with both TCD and echocardiogram. The sensitivity and specificity of TIBA for RLS detection were 75%, positive predictive value 82%, and negative predictive value 67%.CONCLUSIONPFO screening accuracy using TIBA was 75%. Prospective evaluation of CS patients with TIBA and comparison to the gold‐standard TEE should be performed to further guide clinical practice.
How Did a Multi-Institutional Trial Show Feasibility of Electronic Data Capture in Older Patients With Cancer? Results From a Multi-Institutional Qualitative Study (Alliance A171902)
Martin, Nichole , Harlos, Elizabeth, Cook, Kathryn , O’Connor, Jennifer M. , Dodge, Andrew , Guerard, Emily J., Lafky, Jacqueline M., Jatoi, Aminah , Le‐Rademacher, Jennifer , Martin, Nichole A, Harlos, Elizabeth S., Cook, Kathryn D, Le-Rademacher, Jennifer G , Dodge, Andrew B

Mayo Clinic

JCO Clinical Cancer Informatics | April 20, 2021 | Volume: No volume available | Issue: 5 | Pages: 442-449

10.1200/cci.20.00164 | PMID 33877885 Get It

PURPOSE New technology might pose problems for older patients with cancer. This study sought to understand how a trial in older patients with cancer (Alliance A171603) was successful in capturing electronic patient-reported data. METHODS Study personnel were invited via e-mail to participate in semistructured phone interviews, which were audio-recorded and qualitatively analyzed. RESULTS Twenty-four study personnel from the 10 sites were interviewed; three themes emerged. The first was that successful patient-reported electronic data capture shifted work toward patients and toward study personnel at the beginning of the study. One interviewee explained, “I mean it kind of lost all advantages…by being extremely laborious.” Study personnel described how they ensured electronic devices were charged, wireless internet access was up and running, and login codes were available. The second theme was related to the first and dealt with data filtering. Study personnel described high involvement in data gathering; for example, one interviewee described, “I answered on the iPad, whatever they said. They didn't even want to use it at all.” A third theme dealt with advantages of electronic data entry, such as prompt data availability at study completion. Surprisingly, some remarks described how electronic devices brought people together, “Some of the patients, you know, it just gave them a chance to kinda talk about, you know, what was going on.” CONCLUSION High rates of capture of patient-reported electronic data were viewed favorably but occurred in exchange for increased effort from patients and study personnel and in exchange for data that were not always patient-reported in the strictest sense.
Prophylactic Drainage after Appendectomy for Perforated Appendicitis in Adults: A Post Hoc Analysis of an EAST Multi-Center Study
Qian, Sinong , Vasileiou, Georgia , Pust, Gerd Daniel , Zakrison, Tanya L. , Rattan, Rishi , Zielinski, Martin D. , Ray-Zack, Mohamed D. , Group, on behalf of the EAST Appendicitis Study, Alouidor, Reginald, Hing, Kailyn Kwong, Sharp, Victoria , Serena, Thomas , Kasotakis, George , Perez, Sean, Allmond, Stacie L., Long, Bruce, Barth, Nadine, Roman, Janika San, Lawless, Ryan A. , Cralley, Alexis , Gelbard, Rondi B. , Szczepanski, Crystal, Eyer, Steven D., Proulx, Kaitlyn, Wild, Jeffrey, Young, Katelyn , Teicher, Erik J. , Lita, Elena, Morris, David S. , Juarez, Laura, Catalano, Richard D., Turay, David, Roberts, Jennifer C., Kaafarani, Haytham M.A., Eid, Ahmed , Kanaan, Tala , Portillo, Victor, Collom, Morgan, Eddine, Savo Bou Zein , Tabrizi, Maryam B. , Elsharkawy, Ahmed Elsayed Mohammed , Yeh, D. Dante, Evans, David , Vázquez, Daniel , Saxe, Jonathan M. , Jacobson, Lewis E. , Behrens, Brandon, Joseph, Bellal , Mull, Jennifer, Pasley, Jason, O’Meara, Lindsay , Gök, Ali , To, Jocelyn, Bradley, Matthew J. , Zielinski, Martin, Zeeshan, Muhammad , Namias, Nicholas , Yeh, D. Dante , Group, on behalf of the EAST Appendicitis Study, Morris, David, Cullinane, Daniel C. , Roberts, Jennifer C., Dodgion, Christopher M. , Yeh, D. Dante, Vazquez, Daniel E., Schreiber, Martin J. , Nahmias, Jeffry T. , Sun, Beatrice J. , Crandall, Marie , Rodríguez, Carlos

Mayo Clinic

Surgical Infections | April 20, 2021 | Volume: 22 | Issue: 8 | Pages: 780-786

10.1089/sur.2019.258 | PMID 33877912 Get It

Recognizing and Preventing Participant Deception in Online Nicotine and Tobacco Research Studies: Suggested Tactics and a Call to Action
Heffner, Jaimee L. , Watson, Noreen L , Dahne, Jennifer , Croghan, Ivana T. , Kelly, Megan M. , McClure, Jennifer B. , Bars, Matthew P, Thrul, Johannes , Meier, Eric , Meier, Eric N. , Croghan, Ivana, Meier, Eric

Mayo Clinic

Nicotine & Tobacco Research | April 16, 2021 | Volume: 23 | Issue: 10 | Pages: 1810-1812

10.1093/ntr/ntab077 | PMID 33876244 Get It